Kenneth S. Suslick
| Kenneth S. Suslick | |
|---|---|
 |
|
| Born | 1952 Chicago |
| Nationality | American |
| Fields | Chemistry |
| Institutions | University of Illinois at Urbana-Champaign |
| Alma mater | California Institute of Technology, Stanford University |
| Doctoral advisor | James P. Collman and John I. Brauman |
| Known for | Sonochemistry, sonoluminescence, chemical sensors and artificial olfaction |
Kenneth S. Suslick (born 1952) is the Marvin T. Schmidt Professor of Chemistry, Professor of Materials Science & Engineering, and Professor of the Beckman Institute for Advanced Science & Engineering at the University of Illinois at Urbana-Champaign. He is the world’s leading expert on the chemical and physical effects of ultrasound and has received numerous awards for his work on sonochemistry and sonoluminescence. Professor Suslick has also introduced new technology in chemical sensing, specifically the use of colorimetric sensor arrays as an optoelectronic nose.
Ken Suslick received his B.S. from the California Institute of Technology in 1974, his Ph.D. from Stanford University in 1978, and came to the University of Illinois at Urbana-Champaign immediately thereafter. He was promoted to full professor at the age of 35, held the first William H. & Janet Lycan Professorship in Chemistry, and then in 2004 became the inaugural Marvin T. Schmidt Professor of Chemistry at the University of Illinois.
Professor Suslick is a Fellow of the American Chemical Society, the Royal Society of Chemistry, the Materials Research Society, the Acoustical Society of America, the American Physical Society, and the American Association for the Advancement of Science.
Professor Suslick has mentored more than 66 Ph.D. students and 33 postdoctoral associates. He has published more than 360 scientific papers, edited four books, and holds more than 42 patents and patent applications. His papers have been cited more than 37,000 times and his h-index is 100 (i.e., 100 papers with 100 or more citations), as of June, 2016. His six most cited papers are listed below.
In addition to his academic research, Professor Suslick has had significant entrepreneurial experience. He was the lead consultant for Molecular Biosystems Inc. and part of the team that commercialized the first echo contrast agent for medical sonography, Albunex™, which became Optison™ by GE Healthcare. In addition, he was the founding consultant for VivoRx Pharmaceuticals and helped invent and commercialize Abraxane™, albumin microspheres with a paclitaxel core, which is the predominant current delivery system for taxol chemotherapy for breast cancer; VivoRx became He then co-founded ChemSensing and its successor, iSense Systems/Metabolomx in Mountain View, for the commercialization of the Suslick group's optoelectronic nose technology with particular focus on biomedical applications of this unique sensor technology.
...
Wikipedia